公开(公告)号：US20240306693A1

公开(公告)日：2024-09-19

申请号：US18263830

申请日：2022-02-02

申请人： BONUMOSE, INC.

发明人： Daniel Joseph WICHELECKI ,  Edwin O. ROGERS

IPC分类号： A23L33/20 ,  A21D2/26 ,  A23L33/17 ,  C12N9/12 ,  C12N9/90 ,  C12N9/92

CPC分类号： A23L33/20 ,  A21D2/26 ,  A23L33/17 ,  C12N9/1205 ,  C12N9/90 ,  C12N9/92 ,  C12Y207/01144 ,  C12Y401/02022 ,  C12Y503/01009 ,  C12Y504/02002

摘要： The invention relates to preparation of food ingredients enriched with a low-glycemic sugar replacement through enzymatic conversion. Food ingredients may be enriched with, for example, D-tagatose, D-allulose, D-allose, D-mannose, D-talose, and/or inositol by enzymatically converting saccharides found in flour, meal, ground tuber, ground pulse, ground bark, starch, malted grain or malt extract, maltodextrin, cellulose, cellodextrin, any of their derivatives (e.g., amylose, amylopectin, dextrin, cellobiose, etc.), and/or sucrose into D-tagatose, D-allulose, D-allose, D-mannose, D-talose and/or inositol. The enriched material can be used as a food ingredient instead of the low-glycemic sugar being purified for use as a food ingredient.

公开(公告)号：US20240301022A1

公开(公告)日：2024-09-12

申请号：US18598878

申请日：2024-03-07

申请人： Aston University

发明人： Michael J. Tisdale ,  Steven T. Russell

IPC分类号： C07K14/47 ,  A23L33/17 ,  A61K9/00 ,  A61K31/137 ,  A61K31/138 ,  A61K38/17 ,  A61K38/26 ,  A61K38/28 ,  A61K45/06 ,  A61K47/60 ,  A61K47/61

CPC分类号： C07K14/473 ,  A23L33/17 ,  A61K9/0014 ,  A61K9/0043 ,  A61K9/0053 ,  A61K31/137 ,  A61K31/138 ,  A61K38/17 ,  A61K38/1709 ,  A61K38/1741 ,  A61K38/26 ,  A61K38/28 ,  A61K45/06 ,  A61K47/60 ,  A61K47/61

摘要： The invention provides formulations and methods for ameliorating symptoms associated with metabolic disorders, such as cachexia, hypoglycemia, obesity, diabetes, and the like by administering Zn-α2-glycoproteins or a functional fragment thereof, alone or in combination with additional agents, such as β adrenergin receptor agonists, β adrenergin receptor antagonists, and/or glycemic control agents.

公开(公告)号：US12064449B2

公开(公告)日：2024-08-20

申请号：US16972090

申请日：2019-06-04

申请人： Sidero Bioscience, LLC

发明人： Darren Wolfe ,  James Connor

IPC分类号： A61K33/26 ,  A23L33/00 ,  A23L33/14 ,  A23L33/165 ,  A23L33/17 ,  A61K35/74 ,  A61K36/06

CPC分类号： A61K33/26 ,  A23L33/14 ,  A23L33/165 ,  A23L33/17 ,  A23L33/30 ,  A61K35/74 ,  A61K36/06

摘要： Disclosed is a composition comprising a microbe expressing ferritin. The composition also comprises elemental iron in an amount of at least 3% by weight on a dry matter basis of the microbe expressing ferritin and the elemental iron. Also disclosed are ingestibles, dietary supplements, and pharmaceutical compositions comprising the composition. Also disclosed are methods for treating a subject comprising administering the composition to the subject. Also disclosed are methods of altering the composition of the gut bacterial microbiome in a subject, the method comprising administering the composition to the subject.

公开(公告)号：US12059450B2

公开(公告)日：2024-08-13

申请号：US17281808

申请日：2019-10-02

申请人： Korea University Research And Business Foundation ,  CHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION

发明人： Min-Jeong Shin ,  Hyeon Soo Kim ,  Inhyeok Jeong ,  Eun Hye Yoo ,  Ji Hyung Chung

IPC分类号： A61K38/17 ,  A23L33/17 ,  A61P35/00

CPC分类号： A61K38/1709 ,  A23L33/17 ,  A61P35/00

摘要： The present invention pertains to an anticancer composition containing IF1 (ATPase inhibitory factor 1). The IF1 (ATPase inhibitory factor 1) according to the present invention has the effect of releasing extracellular ATP, induces cytotoxicity in various cancer cells and exhibits anticancer efficacy, and is thus very useful as an active ingredient of a powerful anticancer agent.

公开(公告)号：US20240233865A1

公开(公告)日：2024-07-11

申请号：US18401657

申请日：2024-01-01

申请人： Prose Foods, Inc.

发明人： Hermann Broder Schmidt ,  Daniel Griffith

IPC分类号： G16B20/00 ,  A23L33/17

CPC分类号： G16B20/00 ,  A23L33/17

摘要： A method of predicting at least one target food function of a candidate protein comprises providing an amino acid sequence for the candidate protein; computer processing, by at least one processor executing a trained computer model, the amino acid sequence of the candidate protein to predict a set of candidate amino acid sequences having intrinsic disorder, wherein the intrinsic disorder may comprise a lack of stable secondary structure along at least about 10% of the length of an individual candidate amino acid sequence; and computer processing, by at least one processor executing a trained computer model, the set of candidate amino acid sequences to generate an output that may be indicative of the predicted target food function or target food functions of the candidate protein. Compositions and food products comprising the candidate protein are also disclosed.

公开(公告)号：US11975052B2

公开(公告)日：2024-05-07

申请号：US17156534

申请日：2021-01-23

申请人： Chenland Nutritionals Inc. ,  Qingdao Chenland Pharmaceutical Technology Development Co., Ltd.

发明人： Shengcan Zou ,  Zengliang Zhang ,  Jiancheng Zong ,  Wenyu Li ,  Xin Li ,  Li Li ,  Shanglong Wang ,  Lei Zong

IPC分类号： A61K38/39 ,  A23J3/34 ,  A23L29/281 ,  A23L33/00 ,  A23L33/105 ,  A23L33/155 ,  A23L33/16 ,  A23L33/17 ,  A61K31/122 ,  A61K31/593 ,  A61K33/06 ,  A61K36/126 ,  A61K36/39 ,  A61K36/46 ,  A61P19/00

CPC分类号： A61K38/39 ,  A23L29/284 ,  A23L33/105 ,  A23L33/155 ,  A23L33/16 ,  A23L33/17 ,  A23L33/40 ,  A61K31/122 ,  A61K31/593 ,  A61K33/06 ,  A61K36/126 ,  A61K36/39 ,  A61K36/46 ,  A61P19/00 ,  A23J3/342 ,  A23V2002/00 ,  A23V2250/5422 ,  A61K2236/31 ,  A61K2236/333 ,  A61K2236/37 ,  A61K2236/51 ,  A61K2236/53

摘要： A compound composition for improving bone health and preparation and application thereof are provided. The compound composition is prepared by combining a traditional Chinese medicine extract with chicken cartilage collagen, magnesium, vitamin K2 and vitamin D3. The compound composition overcomes the food safety risk of the existing osteoporosis preventive drugs by adding the traditional Chinese medicine extract for improving osteoporosis and promoting bone health. And the compound composition disclosed can be used as a dietary supplement or health food raw material for preventing or treating osteoporosis. Therefore, the compound composition disclosed is suitable for promotion and application.

公开(公告)号：US11889844B2

公开(公告)日：2024-02-06

申请号：US16640134

申请日：2018-10-17

申请人： GEA Food Solutions Bakel B.V.

发明人： Martinus Johannes Wilhelmus Verhoeven

IPC分类号： A23B4/09 ,  A23K10/20 ,  A23L33/17 ,  A01M1/20 ,  A01N1/00 ,  A23J1/00 ,  A23L3/375

CPC分类号： A23B4/09 ,  A01M1/2094 ,  A01N1/00 ,  A23J1/00 ,  A23K10/20 ,  A23L3/375 ,  A23L33/17 ,  A23V2002/00

摘要： The present invention relates to a method to treat insects in order to produce a human nutrition and/or an animal feed. The treatment involves at reducing and preferably stopping the autolysis of the insects, preferably using a cooling treatment step. The present invention further relates to a line to process insects.

公开(公告)号：US11826331B2

公开(公告)日：2023-11-28

申请号：US16345880

申请日：2017-10-30

申请人： The Cleveland Clinic Foundation

发明人： John Kirwan ,  Suzy Comhair ,  Kewal Asosingh

IPC分类号： A61K31/20 ,  A23L27/00 ,  A23L33/12 ,  A23L33/17 ,  A23L33/125 ,  A23L33/00 ,  A61P11/06 ,  A23D9/00 ,  A61K9/00

CPC分类号： A61K31/20 ,  A23D9/00 ,  A23L27/00 ,  A23L33/12 ,  A23L33/125 ,  A23L33/17 ,  A23L33/40 ,  A61K9/0019 ,  A61K9/0056 ,  A61P11/06 ,  A23V2002/00

摘要： Provided herein are compositions, articles of manufacture, food products, and methods for treating certain conditions, such as fibrotic disease (e.g., asthma). For example, in certain embodiments, provided herein are food products (e.g., that are ketogenic) that contain high levels (e.g., at least 10% by weight of the food product) of capric acid (C10), myristic acid (C14), or combination thereof (e.g., as free fatty acids or as triglycerides). In other embodiments, methods are provided for receiving an order for such a food product, and shipping the food product to a subject with fibrotic disease (e.g., after receiving or verifying prescription information). In some embodiments, methods are provided of administering or providing a composition to a subject such that the subject receives at least 50 grams per day (e.g., 200 grams per day), on multiple days, of capric acid (C10), myristic acid (C14), or combination thereof.

公开(公告)号：US11813273B2

公开(公告)日：2023-11-14

申请号：US16992928

申请日：2020-08-13

申请人： SOCIÉTÉ DES PRODUITS NESTLÉ S.A.

发明人： Marie Noelle Horcajada ,  Fanny Membrez ,  Denis Breuille ,  Claire Boutry

IPC分类号： A61K31/7048 ,  A23L33/105 ,  A23L33/12 ,  A61K31/12 ,  A23L33/19 ,  A23L33/17 ,  A61K31/352 ,  A61K45/06 ,  A23L33/00 ,  A61K31/353 ,  A61K38/17 ,  A61K38/00 ,  A61K31/202

CPC分类号： A61K31/7048 ,  A23L33/105 ,  A23L33/12 ,  A23L33/17 ,  A23L33/19 ,  A23L33/40 ,  A61K31/12 ,  A61K31/202 ,  A61K31/352 ,  A61K31/353 ,  A61K38/1709 ,  A61K45/06 ,  A23V2002/00 ,  A61K38/00 ,  A23V2002/00 ,  A23V2200/316 ,  A23V2250/1868 ,  A23V2250/2116 ,  A23V2250/21168 ,  A23V2250/2117

摘要： A composition comprising one or more polyphenols, such as oleuropein, rutin, curcumin or quercetin, can treat or prevent sarcopenia, reduce a loss of muscle functionality (e.g. muscle strength, gait speed, etc.), increase muscle functionality, and/or improve recovery of muscle functionality after muscle atrophy. The composition can be administered to an individual who is elderly and/or frail.

公开(公告)号：US20230322904A1

公开(公告)日：2023-10-12

申请号：US18343523

申请日：2023-06-28

申请人： Paleo B.V.

发明人： Hermes Sanctorum ,  Andy de Jong

IPC分类号： C07K14/805 ,  A23J3/22 ,  A23J3/04 ,  A23L33/17 ,  A23J1/00

CPC分类号： C07K14/805 ,  A23J3/227 ,  A23J3/04 ,  A23L33/17 ,  A23J1/008

摘要： Described herein is a meat substitute or food ingredient comprising an animal myoglobin protein, gene construct comprising a nucleic acid encoding said protein, a host cell comprising said gene construct and a method for producing said myoglobin or said meat substitute.